Delox Global

The Standard for Critical Environment Safety 

Contamination is not an acceptable risk. Delox develops proprietary bio-decontamination solutions where the margin for error is zero.

Delox Global

ABOUT US

Delox is an international technology company developing advanced bio-decontamination solutions for the world’s most demanding environments.

Our work sits at the intersection of chemistry, biochemistry, and materials science, where precision is not optional and the margin for error is zero.

With an active presence across Europe and North America, and backed by institutional investors and long-term strategic partners, Delox is positioned to lead the next generation of contamination control solutions on a global scale.

Delox Global
Delox Global
Delox Global

MISSION & PURPOSE

To make critical environments safer, through rigorous science, proprietary technology, and an unwavering commitment to precision.

The world faces growing challenges in contamination control. Antimicrobial resistance, healthcare-associated infections, and constantly evolving regulatory demands are pressuring organizations worldwide to do more, and to do it better.

Delox exists to meet that pressure. Not with generic solutions, but with technology developed specifically for contexts where failure is not an option.

Delox Global

APPROACH

Our approach begins in science and ends in the field. We have developed a proprietary solid formulation of hydrogen peroxide technology, a platform that enables controlled, residue-free decontamination with proven efficacy, tailored to the real complexity of healthcare, pharmaceutical, laboratory, and industrial settings.

We don’t sell products. We build partnerships with organizations operating in highly controlled environments that need a technical partner they can rely on. Today and in the future.

Contact us Request a demo
Delox Global

OUR STORY

Delox originated from a research programme initiated at the Faculty of Sciences of the University of Lisbon, focused on exploring new approaches to the controlled release of hydrogen peroxide.

Over time, this research demonstrated strong potential for bio-decontamination applications and laid the scientific foundation for the development of DeloxHP, Delox’s proprietary solid hydrogen peroxide technology.

In 2018, Delox was established as a university spin-off with a clear objective: to translate scientific research into practical, scalable solutions for contamination control. Since then, Delox has continued to advance its technology, strengthen its capabilities and expand the application of its solutions across critical environments.

Beginning of Collaboration and Fundamental Research

Professors João Silva and Fernando Antunes begin their collaboration at the Faculty of Sciences of the University of Lisbon, exploring porous materials for the controlled release of hydrogen peroxide. Their work, initially focused on therapeutic applications, is kept secret with the aim of founding a company, facing risks and funding limitations.

Fadhil Musa Joins the Team

Fadhil Musa is part of the team as a master’s student in Biochemistry, developing his thesis on the research topic of materials for hydrogen peroxide release, under the supervision of Fernando Antunes and João Silva.

Pivot point for bio-decontamination and the birth of Delox.

Fernando Antunes and Fadhil Musa are participating in the COHiTEC program, which is catalyzing a strategic reorientation of the project. Experimental discoveries and mentoring lead to a focus on bio-decontamination, resulting in the official launch of the project, named Delox, at the end of the year.

Delox Foundation as a Spin-off

Delox is formally established as a spin-off company from the Faculty of Sciences of the University of Lisbon, consolidating years of research in chemistry, biochemistry and materials science.

European recognition for DeloxAir.

Delox wins the EIC Accelerator for DeloxAir, a highly competitive European programme with an approval rate of only 3%. This recognition reinforces the technology’s potential and marks a new stage in the company’s growth.

Current Focus and Mission

Currently, Delox is dedicated to solving critical challenges such as antimicrobial resistance, hospital infections, and microbial contamination, combining scientific excellence with an entrepreneurial mindset to provide high-performance bio-decontamination solutions globally.

Delox Global